Literature DB >> 23830658

Fulminant viral hepatitis.

Saumya Jayakumar1, Raiyan Chowdhury, Carrie Ye, Constantine J Karvellas.   

Abstract

Acute liver failure (ALF) is a condition wherein the previously healthy liver rapidly deteriorates, resulting in jaundice, encephalopathy, and coagulopathy. There are approximately 2000 cases per year of ALF in the United States. Viral causes (fulminant viral hepatitis [FVH]) are the predominant cause of ALF in developing countries. Given the ease of spread of viral hepatitis and the high morbidity and mortality associated with ALF, a systematic approach to the diagnosis and treatment of FVH is required. In this review, the authors describe the viral causes of ALF and review the intensive care unit management of patients with FVH.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute liver failure; Cerebral edema; Fulminant viral hepatitis; Hepatitis A; Hepatitis B; Liver transplantation

Mesh:

Substances:

Year:  2013        PMID: 23830658     DOI: 10.1016/j.ccc.2013.03.013

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  6 in total

1.  Cross-Sectional Study of Hepatitis A Virus Infection in the Pantanal Population before Vaccine Implementation in Brazil: Usage of Non-Invasive Specimen Collection.

Authors:  Renata Santos Tourinho; Adilson José de Almeida; Livia Melo Villar; Paula Guerra Murat; Gina Jonasson Mousquer Capelin; Ana Rita Coimbra Motta Castro; Vanessa Salete de Paula
Journal:  Int J Environ Res Public Health       Date:  2015-06-30       Impact factor: 3.390

2.  Changes in cellular proliferation and plasma products are associated with liver failure.

Authors:  Juliana Gil Melgaço; Frederico Marianetti Soriani; Pedro Henrique Ferreira Sucupira; Leonardo Assaf Pinheiro; Yasmine Rangel Vieira; Jaqueline Mendes de Oliveira; Lia Laura Lewis-Ximenez; Cristina Carvalho Vianna Araújo; Lúcio Filgueiras Pacheco-Moreira; Gustavo Batista Menezes; Oswaldo Gonçalves Cruz; Claudia Lamarca Vitral; Marcelo Alves Pinto
Journal:  World J Hepatol       Date:  2016-11-18

3.  Complement System as a Target for Therapies to Control Liver Regeneration/Damage in Acute Liver Failure Induced by Viral Hepatitis.

Authors:  Juliana Gil Melgaço; Carlos Eduardo Veloso; Lúcio Filgueiras Pacheco-Moreira; Claudia Lamarca Vitral; Marcelo Alves Pinto
Journal:  J Immunol Res       Date:  2018-10-08       Impact factor: 4.818

Review 4.  Genomic Diversity of Hepatitis B Virus Infection Associated With Fulminant Hepatitis B Development.

Authors:  Thomas Mina; Samad Amini Bavil Olyaee; Frank Tacke; Piet Maes; Marc Van Ranst; Mahmoud Reza Pourkarim
Journal:  Hepat Mon       Date:  2015-06-23       Impact factor: 0.660

5.  Cynomolgus monkeys (Macaca fascicularis) experimentally infected with B19V and hepatitis A virus: no evidence of the co-infection as a cause of acute liver failure.

Authors:  Luciane Almeida Amado Leon; Renato Sergio Marchevsky; Ana Maria Coimbra Gaspar; Rita de Cassia Nasser Cubel Garcia; Adilson José de Almeida; Marcelo Pelajo-Machado; Tatiana Xavier de Castro; Jussara Pereira do Nascimento; Kevin E Brown; Marcelo Alves Pinto
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-04       Impact factor: 2.743

6.  Validation of the Model for End-Stage Liver Disease Score Criteria in Urgent Liver Transplantation for Acute Flare Up of Hepatitis B.

Authors:  Wei-Chen Lee; Ching-Song Lee; Yu-Chao Wang; Chih-Hsien Cheng; Tsung-Han Wu; Chen-Fang Lee; Ruey-Shyang Soong; Ming-Ling Chang; Ting-Jung Wu; Hong-Shiue Chou; Kun-Ming Chan
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.